379 related articles for article (PubMed ID: 38012525)
1. Exosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing.
Aslan C; Zolbanin NM; Faraji F; Jafari R
Mol Biotechnol; 2023 Nov; ():. PubMed ID: 38012525
[TBL] [Abstract][Full Text] [Related]
2. Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications.
Bhattacharjee G; Gohil N; Khambhati K; Mani I; Maurya R; Karapurkar JK; Gohil J; Chu DT; Vu-Thi H; Alzahrani KJ; Show PL; Rawal RM; Ramakrishna S; Singh V
J Control Release; 2022 Mar; 343():703-723. PubMed ID: 35149141
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
7. Gene Editing in Clinical Practice: Where are We?
Mittal RD
Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
Sharma G; Sharma AR; Bhattacharya M; Lee SS; Chakraborty C
Mol Ther; 2021 Feb; 29(2):571-586. PubMed ID: 33238136
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
Zhang D; Zhang Z; Unver T; Zhang B
J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
Okoli A; Okeke MI; Tryland M; Moens U
Viruses; 2018 Jan; 10(1):. PubMed ID: 29361752
[TBL] [Abstract][Full Text] [Related]
12. Advances in genome editing technology and its promising application in evolutionary and ecological studies.
Chen L; Tang L; Xiang H; Jin L; Li Q; Dong Y; Wang W; Zhang G
Gigascience; 2014; 3():24. PubMed ID: 25414792
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
[TBL] [Abstract][Full Text] [Related]
14. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
Amritha PP; Shah JM
Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
[TBL] [Abstract][Full Text] [Related]
15. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
16. Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing.
Lyu P; Wang L; Lu B
Life (Basel); 2020 Dec; 10(12):. PubMed ID: 33371215
[TBL] [Abstract][Full Text] [Related]
17. Various Aspects of a Gene Editing System-CRISPR-Cas9.
Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
[TBL] [Abstract][Full Text] [Related]
18. Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing.
Duan L; Ouyang K; Wang J; Xu L; Xu X; Wen C; Xie Y; Liang Y; Xia J
Chembiochem; 2021 Dec; 22(24):3360-3368. PubMed ID: 34418266
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical non-viral vectors exploited for
Rouatbi N; McGlynn T; Al-Jamal KT
Biomater Sci; 2022 Jun; 10(13):3410-3432. PubMed ID: 35604372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]